(Q48635503)

13 February 2018

title

Deficits of [3H]D-aspartate binding to glutamate uptake sites in striatal and accumbens tissue in patients with schizophrenia. (English)

1 reference

13 February 2018

1 reference

1 reference

4

1 reference

13 February 2018

author name string

Aparicio-Legarza MI

series ordinal

1

1 reference

13 February 2018

Cutts AJ

series ordinal

2

1 reference

13 February 2018

Davis B

series ordinal

3

1 reference

13 February 2018

language of work or name

English

0 references

publication date

1 August 1997

1 reference

13 February 2018

number of pages

4

1 reference

inferred from page(s)

published in

Neuroscience Letters

1 reference

13 February 2018

volume

232

1 reference

13 February 2018

issue

1

1 reference

13 February 2018

page(s)

13-16

1 reference

13 February 2018

Interactions between glutamatergic and monoaminergic systems within the basal ganglia-implications for schizophrenia and Parkinson's disease

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900563-6

7 January 2021

Reduced high-affinity glutamate uptake sites in the brains of patients with Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900563-6

7 January 2021

Sodium dependent D-[3H]aspartate binding in cerebral cortex in patients with Alzheimer's and Parkinson's diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900563-6

7 January 2021

D-aspartate binding to the glutamate uptake site in human brain tissue ? effects of leucotomy

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900563-6

7 January 2021

Frontal cortical and left temporal glutamatergic dysfunction in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900563-6

7 January 2021

Biochemical evidence for glutamate as neurotransmitter in corticostriatal and corticothalamic fibres in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900563-6

7 January 2021

Properties of [3H]AMPA binding in postmortem human brain from psychotic subjects and controls: increases in caudate nucleus associated with suicide.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900563-6

7 January 2021

Demonstration of glutamate/aspartate uptake activity in nerve endings by use of antibodies recognizing exogenous D-aspartate

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900563-6

7 January 2021

Increases in strychnine-insensitive glycine binding sites in cerebral cortex of chronic schizophrenics: evidence for glutamate hypothesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900563-6

7 January 2021

Recent advances in the phencyclidine model of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900563-6

7 January 2021

Quantitative autoradiographic analysis of glutamate binding sites in the hippocampal formation in normal and schizophrenic brain post mortem

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900563-6

7 January 2021

Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900563-6

7 January 2021

(3H]MK-801 binding sites in postmortem brain regions of schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900563-6

7 January 2021

Alpha-[3H]amino-3-hydroxy-5-methylisoxazole-4-propionic acid binding to human cerebral cortical membranes: minimal changes in postmortem brains of chronic schizophrenics

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900563-6

7 January 2021

Increased [3H]kainic acid binding in the prefrontal cortex in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900563-6

7 January 2021

Normal cerebrospinal fluid and brain glutamate levels in schizophrenia do not support the hypothesis of glutamatergic neuronal dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900563-6

7 January 2021

Deficient NMDA-mediated glutamate release from synaptosomes of schizophrenics

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900563-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900563-6

7 January 2021

10.1016/S0304-3940(97)00563-6

Identifiers

DOI

1 reference

13 February 2018

1 reference

13 February 2018